NICE TAs

11/08/2020

TA276: Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis

11/08/2020

TA256: Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation

11/08/2020

TA261: Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

11/08/2020

TA267: Ivabradine for treating chronic heart failure

11/08/2020

TA269: Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanoma

11/08/2020

TA266: Mannitol dry powder for inhalation for treating cystic fibrosis

11/08/2020

TA284: Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer

11/08/2020

TA301: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (replaced TA271)

11/08/2020

TA386: Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis (replaced TA289)

10/08/2020

TA421: Everolimus with exemestane for treating advanced breast cancer after endocrine therapy (replaced TA295)

10/08/2020

TA285: Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer

10/08/2020

TA290: Mirabegron for treating symptoms of overactive bladder

10/08/2020

TA337: Rifaximin for preventing episodes of overt hepatic encephalopathy

05/08/2020

TA333: Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment

05/08/2020

TA294: Aflibercept solution for injection for treating wet age‑related macular degeneration

05/08/2020

TA287: Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism

05/08/2020

TA275: Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation

05/08/2020

TA422: Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (replaced TA296)

05/08/2020

TA640: Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant

05/08/2020

TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people